Skin cancer research biobank study
Part of Cancer, Skin clinical trials.
This study collects data and samples from people with skin cancer and healthy volunteers to help research. It may be a way to contribute to future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have been diagnosed with melanoma or another skin cancer, or be a healthy volunteer
- You must be willing to give written permission to take part
- You cannot join if you are not willing or able to give your permission
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects and stores biological samples (biospecimens) from people with skin conditions, people at risk, or healthy volunteers. It helps researchers better understand dermatologic diseases and support future skin research.
This research study analyzes blood and tissue samples from melanoma patients to identify biological markers that could help doctors better understand and treat the disease. Researchers will examine archived tissue samples and blood work to develop improved diagnostic tools.
This study collects blood samples and health information from people diagnosed with cancer to build a research database. It may help future patients by enabling better understanding and treatment of cancer.
This study looks at the DNA and other biology from skin lesions (like melanoma or unusual pigmented moles) in children and teens. It aims to better understand what these tumors are and how they behave, using tissue samples collected during routine care.
This study collects blood, tissue, or other samples from people with various conditions—including cancer, infections, autoimmune diseases, or healthy volunteers—to help researchers understand these diseases better. Your samples will be stored and used for future medical research.
This study looks at immune and tumor “behavior” markers in people with metastatic melanoma after standard treatment. It may help researchers understand why treatment works for some people and not others by testing blood and skin tumor samples.
Hear when a new Skin Cancer, Non-Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.